Larvol Delta - A-Phase-II-Clinical-Study-Evaluating-the-Combination-Therapy-of-JS212-in-Patients-With-Advanced-Lung-Cancer

AWT020 - Anwita Biosci

JS212 - Shanghai Junshi Biosci

JS207 - Shanghai Junshi Biosci

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Biosci, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT07309276

Dec 31, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next